Dodge & Cox Portfolio holdings
Dodge & Cox, founded in 1930 by Van Duyn Dodge and E. Morris Cox in San Francisco, California, is an independent, employee-owned investment management firm renowned for its disciplined, value-oriented approach to long-term investing. Managing over $350 billion in assets as of late 2024, the firm offers a concise lineup of mutual funds and separate accounts focusing on U.S. and international equities, fixed income, and balanced portfolios, serving individual and institutional investors with a low-turnover, research-driven strategy. Known for its team-based decision-making and contrarian stance—buying undervalued securities others overlook—Dodge & Cox has maintained a consistent philosophy through decades, avoiding trend-chasing and emphasizing fundamentals, even during market volatility like the 2008 crisis. With a tight-knit team of about 300 employees and no proprietary trading, the firm’s commitment to simplicity, low fees, and client alignment has earned it a loyal following and a reputation as a steadfast player in asset management.
Top Buys
| 1 |
Johnson Controls International
JCI
|
$1.14B |
| 2 |
DXC Technology
DXC
|
$1.03B |
| 3 |
Eli Lilly
LLY
|
$491M |
| 4 |
Target
TGT
|
$476M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
$472M |
Top Sells
| 1 |
Petrobras Class A
PBR.A
|
$895M |
| 2 |
Elevance Health
ELV
|
$522M |
| 3 |
Corning
GLW
|
$375M |
| 4 |
Synopsys
SNPS
|
$363M |
| 5 |
Bank of America
BAC
|
$360M |
Sector Composition
| 1 | Financials | 25.09% |
| 2 | Healthcare | 17.63% |
| 3 | Communication Services | 16.71% |
| 4 | Technology | 14.6% |
| 5 | Energy | 7.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AstraZeneca
AZN
$248B
| $1.93B | 1.63% | 56,669,449 -237,050 | -0.4% | -$8.08M |
|
|
TFCFA
27
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $1.93B | 1.63% | 68,166,289 -243,400 | -0.4% | -$6.9M |
|
28
UnitedHealth
UNH
$281B
| $1.87B | 1.57% | 10,070,308 -71,875 | -0.7% | -$13.3M |
|
29
Bristol-Myers Squibb
BMY
$96B
| $1.65B | 1.39% | 29,579,461 +459,271 | +2% | +$25.6M |
|
30
Walmart
WMT
$774B
| $1.61B | 1.36% | 21,249,526 -135,557 | -0.6% | -$10.3M |
|
|
APC
31
DELISTED
Anadarko Petroleum
APC
| $1.49B | 1.25% | 32,794,208 +9,965,600 | +44% | +$452M |
|
32
Union Pacific
UNP
$133B
| $1.47B | 1.24% | 13,482,029 -166,379 | -1% | -$18.1M |
|
33
Booking.com
BKNG
$181B
| $1.45B | 1.23% | 776,833 -41,970 | -5% | -$78.5M |
|
34
APA Corp
APA
$8.31B
| $1.43B | 1.21% | 29,922,731 +1,152,395 | +4% | +$55.2M |
|
|
S
35
DELISTED
Sprint Corporation
S
| $1.41B | 1.19% | 171,472,536 -3,964,281 | -2% | -$32.5M |
|
|
BHI
36
DELISTED
Baker Hughes
BHI
| $1.3B | 1.1% | 23,820,739 -417,030 | -2% | -$22.7M |
|
37
JD.com
JD
$44.1B
| $1.28B | 1.08% | 32,714,191 -8,095,445 | -20% | -$318M |
|
38
Celanese
CE
$5.22B
| $1.12B | 0.94% | 11,757,179 -1,134,176 | -9% | -$108M |
|
39
Suncor Energy
SU
$50.1B
| $1.08B | 0.91% | 36,821,800 +2,587,900 | +8% | +$75.6M |
|
|
40
Target
TGT
$43.6B
| $1.05B | 0.88% | 20,025,223 +9,102,526 | +83% | +$476M |
|
|
41
DXC Technology
DXC
$2.59B
| $1.03B | 0.87% | +13,459,431 | New | +$1.03B |
|
42
NOV
NOV
$4.94B
| $1.03B | 0.87% | 31,339,689 -2,850 | -0% | -$93.9K |
|
43
Medtronic
MDT
$119B
| $1.03B | 0.87% | 11,583,871 -628,405 | -5% | -$55.8M |
|
44
Baidu
BIDU
$32.8B
| $1.02B | 0.86% | 5,679,287 +13,900 | +0.2% | +$2.49M |
|
|
DISH
45
DELISTED
DISH Network Corp.
DISH
| $1.02B | 0.86% | 16,181,380 -32,200 | -0.2% | -$2.02M |
|
46
Liberty Global Class C
LBTYK
$4.07B
| $1.01B | 0.85% | 32,306,221 +3,555,474 | +12% | +$111M |
|
47
Televisa
TV
$1.49B
| $982M | 0.83% | 40,308,617 +2,287,300 | +6% | +$55.7M |
|
48
Truist Financial
TFC
$60.4B
| $941M | 0.79% | 20,714,919 -290,850 | -1% | -$13.2M |
|
49
Merck
MRK
$210B
| $869M | 0.73% | 13,557,699 -131,475 | -1% | -$8.43M |
|
|
MXIM
50
DELISTED
Maxim Integrated Products
MXIM
| $832M | 0.7% | 18,519,734 -296,139 | -2% | -$13.3M |
|